Mc Adam, LLC Vaxxinity, Inc. Transaction History

Mc Adam, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$0.7 - $1.31 $7,000 - $13,100	10,000 Added 14.65%	78,281 $66,000
Q3 2023 Oct 31, 2023	BUY	$1.25 - $3.0 $27,446 - $65,871	21,957 Added 47.4%	68,281 $93,000
Q1 2023 Apr 24, 2023	BUY	$1.43 - $4.24 $66,243 - $196,413	46,324 New	46,324 $105,000

287K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Market Cap $1.12M
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.